UNH
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated historical holders
total: 37
Tiger Global Management UnitedHealth Group Incorporated transactions over time
- Total transactions:
- 5
- New positions:
- 1
- Added:
- 1
- Reduced:
- 3
- Held since:
- 2024 Q2
- Held for:
- 8 quarters
- Latest activity:
- 2026 Q1
Chase Coleman III has been an institutional investor in UnitedHealth Group Incorporated (UNH) since 2024 Q2. According to 2026 Q1 report, Chase Coleman III holds 350,445 shares with a market value of roughly $94.83M representing 0.42% of their equity portfolio. The fund/company first acquired UNH in 2024 Q2, initially purchasing about 2.35M shares. Since the initial investment, Tiger Global Management has made 4 more transactions in this position.
Does Chase Coleman III still hold UNH?
Yes, Chase Coleman III continues to hold UnitedHealth Group Incorporated (UNH). According to their 2026 Q1 report, they maintain a position of 350,445 shares valued at approximately $94.83M, representing 0.42% of their equity portfolio.
When did Chase Coleman III first invest in UNH?
Chase Coleman III first invested in UnitedHealth Group Incorporated (UNH) in 2024 Q2 at the reported quarter-end price of $509.26 per share, acquiring 2,347,600 shares in their initial purchase.
What is Chase Coleman III's average cost basis for UNH?
Based on historical transaction data, Chase Coleman III's estimated cost basis for UnitedHealth Group Incorporated (UNH) is approximately $509.83 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $509.83
- Weighted AVG sell price:
- $496.09
UNH transactions history by Tiger Global Management
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.42%
|
350,445
|
$270.59
|
$94,826,913
|
-16.60% (-69,760)
|
-0.06%
|
|
2025 Q4
|
0.47%
|
420,205
|
$330.11
|
$138,713,873
|
-4.24% (-18,595)
|
-0.02%
|
|
2024 Q4
|
0.84%
|
438,800
|
$505.86
|
$221,971,368
|
-81.45% (-1,926,600)
|
-4.16%
|
|
2024 Q3
|
5.90%
|
2,365,400
|
$584.68
|
$1,383,002,072
|
+0.76% (+17,800)
|
+0.04%
|
|
2024 Q2
|
5.53%
|
2,347,600
|
$509.26
|
$1,195,538,776
|
new
|
+5.53%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.